Special Report: Preparing for Stage 1 of the FDA’s LDTs Final Rule
Considerations for addressing compliance with Stage 1 of the FDA’s lab-developed tests final rule
FDA-lca
Subscribe today for access to
Articles and Reports
How the LDT Final Rule’s Exemptions Apply to Oncology Labs
Regulatory expert explores whether any exclusions might benefit cancer laboratories trying to navigate upcoming compliance deadlines
FDA Watch: FDA Approves Enhanced Cologuard Cancer Test
Test maker Exact Sciences says it expects Cologuard Plus to cut false positives by more than 30 percent
Final FDA Guidance on RUO, IUO Products Raises Compliance Concerns for Labs
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
- « Previous
- 1
- …
- 3
- 4
- 5